Stock Scorecard
Stock Summary for Merck & Co Inc (MRK) - $108.34 as of 1/30/2026 9:57:28 AM EST
Total Score
11 out of 30
Safety Score
55 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for MRK
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for MRK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for MRK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for MRK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for MRK (55 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 7 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for MRK
Financial Details for MRK
Company Overview |
|
|---|---|
| Ticker | MRK |
| Company Name | Merck & Co Inc |
| Country | N/A |
| Description | Merck & Company Inc. (MRK) is a prominent global healthcare leader headquartered in Kenilworth, New Jersey, recognized for its innovative contributions to pharmaceuticals and vaccines aimed at improving health outcomes worldwide. Established in 1891, Merck boasts a diverse product portfolio that addresses critical areas such as oncology, infectious diseases, and cardiovascular health, supported by a strong commitment to research and development. With a focus on strategic collaborations and an extensive clinical pipeline, Merck is poised for continued growth within the biopharmaceutical sector, reinforcing its role as a key player in global health advancements and improving patient care. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/3/2026 |
Stock Price History |
|
| Last Day Price | 108.34 |
| Price 4 Years Ago | 101.27 |
| Last Day Price Updated | 1/30/2026 9:57:28 AM EST |
| Last Day Volume | 13,572,813 |
| Average Daily Volume | 12,887,099 |
| 52-Week High | 112.90 |
| 52-Week Low | 71.26 |
| Last Price to 52 Week Low | 52.03% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.61 |
| Sector PE | 188.49 |
| 5-Year Average PE | 24.06 |
| Free Cash Flow Ratio | 14.80 |
| Industry Free Cash Flow Ratio | 45.34 |
| Sector Free Cash Flow Ratio | 30.14 |
| Current Ratio Most Recent Quarter | 1.66 |
| Total Cash Per Share | 7.32 |
| Book Value Per Share Most Recent Quarter | 20.84 |
| Price to Book Ratio | 5.18 |
| Industry Price to Book Ratio | 8.34 |
| Sector Price to Book Ratio | 57.14 |
| Price to Sales Ratio Twelve Trailing Months | 4.21 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.65 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.56 |
| Analyst Buy Ratings | 15 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 2,482,023,000 |
| Market Capitalization | 268,902,371,820 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 3/16/2026 |
| Previous Dividend Amount | 0.8500 |
| Current Dividend Amount | 0.8500 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 3.28 |
| Trailing Annual Dividend Yield | 3.03% |
| Forward Annual Dividend Rate | 3.40 |
| Forward Annual Dividend Yield | 3.14% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 3.12% |
| 5-Year Average Dividend Yield | 3.01% |
| 1-Year Dividend Growth Rate Percentage | 3.66% |
| 3-Year Dividend Growth Rate Percentage | 1.81% |
| 5-Year Dividend Growth Rate Percentage | 4.97% |
| All-Time Dividend Growth Rate Percentage | 9.06% |
| Dividend Payout Ratio | 43.39% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 87.00% |
| Annual Earnings Growth | 4,589.59% |
| Reported EPS 12 Trailing Months | 7.56 |
| Reported EPS Past Year | 6.93 |
| Reported EPS Prior Year | 7.64 |
| Net Income Twelve Trailing Months | 19,034,000,000 |
| Net Income Past Year | 17,117,000,000 |
| Net Income Prior Year | 365,000,000 |
| Quarterly Revenue Growth YOY | 3.70% |
| 5-Year Revenue Growth | 10.40% |
| Operating Margin Twelve Trailing Months | 40.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 18,169,000,000 |
| Total Cash Past Year | 13,242,000,000 |
| Total Cash Prior Year | 6,841,000,000 |
| Net Cash Position Most Recent Quarter | -21,800,000,000 |
| Net Cash Position Past Year | -21,220,000,000 |
| Long Term Debt Past Year | 34,462,000,000 |
| Long Term Debt Prior Year | 33,683,000,000 |
| Total Debt Most Recent Quarter | 39,969,000,000 |
| Equity to Debt Ratio Past Year | 0.57 |
| Equity to Debt Ratio Most Recent Quarter | 0.56 |
| Total Stockholder Equity Past Year | 46,313,000,000 |
| Total Stockholder Equity Prior Year | 37,581,000,000 |
| Total Stockholder Equity Most Recent Quarter | 51,850,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 13,049,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 5.26 |
| Free Cash Flow Past Year | 18,096,000,000 |
| Free Cash Flow Prior Year | 9,143,000,000 |
Options |
|
| Put/Call Ratio | 0.72 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.38 |
| MACD Signal | 2.15 |
| 20-Day Bollinger Lower Band | 74.77 |
| 20-Day Bollinger Middle Band | 95.78 |
| 20-Day Bollinger Upper Band | 116.80 |
| Beta | 0.30 |
| RSI | 52.37 |
| 50-Day SMA | 86.43 |
| 150-Day SMA | 99.60 |
| 200-Day SMA | 96.52 |
System |
|
| Modified | 1/31/2026 3:42:32 AM EST |